{"DataElement":{"publicId":"2549638","version":"1","preferredName":"Breast Cancer Optical Measurement Histologic Type","preferredDefinition":"Text term to identify a histological diagnostic type for cancerous, benign, or normal tissue based on optical measurements.","longName":"BRSTCA_OPT_HIST_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2503685","version":"1","preferredName":"Breast Carcinoma Optical Measurement Type","preferredDefinition":"A particular type of evaluation method used in breast carcinoma to describe the behavior and properties of light and the interaction of light with tissue.","longName":"BRST_CA_OPT_MSRMT_TP","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3756491","version":"1","preferredName":"Breast Carcinoma Optics Measurement","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.:The branch of physics that describes the behavior and properties of light and the interaction of light with matter.:Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","longName":"C4872:C16940:C25209","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Optics","conceptCode":"C16940","definition":"The branch of physics that describes the behavior and properties of light and the interaction of light with matter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Measurement","conceptCode":"C25209","definition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC5A752A-B13B-1D4D-E040-BB89AD433116","latestVersionIndicator":"Yes","beginDate":"2013-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-10","modifiedBy":"ONEDATA","dateModified":"2013-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2223243","version":"1","preferredName":"Type","preferredDefinition":"A subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F629F5E5-DE63-1DFD-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A3765D4-702E-0E35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2549636","version":"1","preferredName":"Breast Cancer Histologic Type","preferredDefinition":"Histological diagnosis types for cancerous, benign, and normal tissue types.","longName":"BRSTCA_HIST_TP","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Adenoid Cystic","valueDescription":"Adenoid Cystic","ValueMeaning":{"publicId":"2566459","version":"1","preferredName":"Adenoid Cystic","longName":"2566459","preferredDefinition":"An adenoid cystic carcinoma primarily involving the breast. Three morphologic patterns are seen: cribriform, trabecular, and solid. The prognosis is excellent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Adenoid Cystic Carcinoma","conceptCode":"C5130","definition":"An adenoid cystic carcinoma primarily involving the breast.  Three morphologic patterns are seen: cribriform, trabecular, and solid.  The prognosis is excellent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0A8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-89FA-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"ADH","valueDescription":"Atypical Ductal Breast Hyperplasia ","ValueMeaning":{"publicId":"2566837","version":"1","preferredName":"Atypical Ductal Breast Hyperplasia ","longName":"2566837","preferredDefinition":"A benign (not cancer) condition in which there are more cells than normal in the breast lobules and the cells look abnormal under a microscope. Having atypical lobular hyperplasia increases the risk of breast cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Atypical Ductal Hyperplasia","conceptCode":"C8436","definition":"A neoplastic process that arises from the terminal ductal lobular unit of the breast parenchyma.  It is usually solitary and confined to a single lobular unit.  It is characterized by the presence of a monomorphic epithelial proliferation in a cribriform, micropapillary, or solid growth pattern.  Focal architectural features of low grade ductal carcinoma in situ are present.  There is an increased risk for development of invasive breast carcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D222-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8A06-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"CA Cartil Osseous","valueDescription":"Carcinoma with Cartilaginous/Osseous Metaplasia","ValueMeaning":{"publicId":"2566817","version":"1","preferredName":"Carcinoma with Cartilaginous/Osseous Metaplasia","longName":"2566817","preferredDefinition":"An invasive adenocarcinoma characterized by focal or extensive cartilage and/or bone formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma with Cartilaginous and Osseous Metaplasia","conceptCode":"C7683","definition":"An invasive adenocarcinoma characterized by focal or extensive cartilage and/or bone formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D20E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8A27-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"CA Mix Metaplasia","valueDescription":"Carcinoma with Mixed Metaplasia","ValueMeaning":{"publicId":"2566816","version":"1","preferredName":"Carcinoma with Mixed Metaplasia","longName":"2566816","preferredDefinition":"Involving or composed of different kinds.: Transformation of a mature, normal cell or groups of mature cells to other forms of mature cells.  The capacity for malignant transformation of metaplastic cells is a subject of controversy.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed","conceptCode":"C25259","definition":"Involving or composed of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Metaplasia","conceptCode":"C3236","definition":"Transformation of a mature, normal cell or groups of mature cells to other forms of mature cells.  The capacity for malignant transformation of metaplastic cells is a subject of controversy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D20D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8A3C-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"CA Spin Cell Metaplasia","valueDescription":"Carcinoma with Spindle Cell","ValueMeaning":{"publicId":"2566815","version":"1","preferredName":"Carcinoma with Spindle Cell","longName":"2566815","preferredDefinition":"An invasive adenocarcinoma of the breast usually affecting post-menopausal women, characterized by extensive spindle cell metaplasia of the neoplastic glandular cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Adenocarcinoma with Spindle Cell Metaplasia","conceptCode":"C40360","definition":"An invasive adenocarcinoma of the breast usually affecting post-menopausal women, characterized by extensive spindle cell metaplasia of the neoplastic glandular cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D20C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8A51-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"CA Squamous Metaplasia","valueDescription":"Carcinoma with Squamous Metaplasia","ValueMeaning":{"publicId":"2566814","version":"1","preferredName":"Carcinoma with Squamous Metaplasia","longName":"2566814","preferredDefinition":"A morphologic finding indicating the transformation of glandular or transitional epithelial cells to, usually, mature squamous epithelial cells. Representative examples include squamous metaplasia of bronchial epithelium, cervix, urinary bladder, and prostate gland.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Metaplasia","conceptCode":"C3237","definition":"A morphologic finding indicating the transformation of glandular or transitional epithelial cells to, usually, mature squamous epithelial cells.  Representative examples include squamous metaplasia of bronchial epithelium, cervix, urinary bladder, and prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D20B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8A66-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Carcinoma, NOS","valueDescription":"Carcinoma, NOS (Not Otherwise Specified)","ValueMeaning":{"publicId":"2566811","version":"1","preferredName":"Carcinoma, NOS (Not Otherwise Specified)","longName":"2566811","preferredDefinition":"A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D208-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8A7B-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"CIS, NOS","valueDescription":"Carcinoma in Situ, NOS","ValueMeaning":{"publicId":"2566827","version":"1","preferredName":"Carcinoma in Situ, NOS","longName":"2566827","preferredDefinition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma In Situ","conceptCode":"C2917","definition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D218-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8A90-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Comedo/Mucinous","valueDescription":"Comedo/Mucinous","ValueMeaning":{"publicId":"2574526","version":"1","preferredName":"Comedo/Mucinous","longName":"2574526","preferredDefinition":"Comedo; having a black or dark core or plug.: containing or resembling mucin.: The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Comedo","conceptCode":"C26453","definition":"Having a black or dark core or plug.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mucinous","conceptCode":"C14163","definition":"Containing or resembling mucin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F02B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8A9C-0AD9-E044-0003BA3F9857","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Cribiform","valueDescription":"Cribriform","ValueMeaning":{"publicId":"2558564","version":"1","preferredName":"Cribriform","longName":"2558564","preferredDefinition":"Having the appearance of a sieve: containing many perforations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cribriform","conceptCode":"C25731","definition":"Having the appearance of a sieve: containing many perforations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B1D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"HARTLEYG","dateModified":"2016-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8AB1-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Ductal Hyperplasia","valueDescription":"Usual Ductal Breast Hyperplasia ","ValueMeaning":{"publicId":"2566467","version":"1","preferredName":"Usual Ductal Breast Hyperplasia ","longName":"2566467","preferredDefinition":"A neoplastic ductal proliferative lesion of the breast characterized by the formation of secondary lumens and prominent intraductal proliferation of a heterogeneous cellular population that may include epithelial cells, myoepithelial cells, or metaplastic apocrine cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Usual Ductal Hyperplasia","conceptCode":"C27941","definition":"A neoplastic ductal proliferative lesion of the breast characterized by the formation of secondary lumens and prominent intraductal proliferation of a heterogeneous cellular population that may include epithelial cells, myoepithelial cells, or metaplastic apocrine cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0B0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8AC6-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Ductal CA","valueDescription":"Ductal","ValueMeaning":{"publicId":"2558691","version":"1","preferredName":"Ductal","longName":"2558691","preferredDefinition":"Ductal; related to, or having the quality of, a duct.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ductal","conceptCode":"C25732","definition":"Related to, or having the quality of, a duct.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B250-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2010-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8ADB-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Ductal CIS","valueDescription":"Ductal CIS","ValueMeaning":{"publicId":"2566819","version":"1","preferredName":"Ductal CIS","longName":"2566819","preferredDefinition":"A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D210-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8AF0-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Ext Ductal CIS","valueDescription":"Extensive Ductal Carcinoma in situ","ValueMeaning":{"publicId":"2566818","version":"1","preferredName":"Extensive Ductal Carcinoma in situ","longName":"2566818","preferredDefinition":"Large in quantity, range, or spatial extent.: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extensive","conceptCode":"C47863","definition":"Large in quantity, range, or spatial extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D20F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8B05-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Infiltrating Ductal","valueDescription":"Infiltrating Ductal Carcinoma","ValueMeaning":{"publicId":"2574524","version":"1","preferredName":"Infiltrating Ductal Carcinoma","longName":"2574524","preferredDefinition":"Invasive ductal carcinoma is the most common type of invasive breast carcinoma (accounting for approximately 70% of breast carcinomas). The gross appearance is usually typical with an irregular stellate outline. Microscopically, randomly arranged epithelial elements are seen. When large sheets of malignant cells are present, necrosis may be seen. With adequate tissue sampling, in situ carcinoma can be demonstrated in association with the infiltrating carcinoma. The in situ component is nearly always ductal but occasionally may be lobular or both. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma of No Special Type","conceptCode":"C4194","definition":"A term that refers to a large and heterogeneous group of invasive breast carcinomas that cannot be classified morphologically as any of the special histological types. (WHO 2019)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F029-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8B11-0AD9-E044-0003BA3F9857","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Infiltrating Lobular","valueDescription":"Infiltrating Lobular Carcinoma","ValueMeaning":{"publicId":"2574525","version":"1","preferredName":"Infiltrating Lobular Carcinoma","longName":"2574525","preferredDefinition":"An infiltrating lobular adenocarcinoma.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Lobular Carcinoma","conceptCode":"C7950","definition":"An infiltrating lobular adenocarcinoma of the breast.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F02A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8B1D-0AD9-E044-0003BA3F9857","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Lobular CA","valueDescription":"Lobular","ValueMeaning":{"publicId":"2559066","version":"1","preferredName":"Lobular","longName":"2559066","preferredDefinition":"Lobular; of or relating to or resembling a lobule.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lobular","conceptCode":"C25557","definition":"Of or relating to or resembling a lobule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B3C7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2010-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8B32-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Lobular Neoplasia","valueDescription":"Lobular Neoplasia (LCIS, ALH)","ValueMeaning":{"publicId":"2566823","version":"1","preferredName":"Lobular Neoplasia (LCIS, ALH)","longName":"2566823v1.00","preferredDefinition":"A spectrum of non-invasive neoplastic lesions that arise from the terminal ductal lobular units of the breast.  There is atypical small epithelial cell proliferation.  Pagetoid involvement of the terminal ducts may or may not be present.  In the minority of cases, there is a risk for subsequent development of invasive ductal or invasive lobular carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lobular Neoplasia","conceptCode":"C27939","definition":"A spectrum of non-invasive neoplastic lesions that arise from the terminal ductal lobular units of the breast.  There is atypical small epithelial cell proliferation.  Pagetoid involvement of the terminal ducts may or may not be present.  In the minority of cases, there is a risk for subsequent development of invasive ductal or invasive lobular carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D214-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8B47-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Medullary","valueDescription":"Medullary Carcinoma","ValueMeaning":{"publicId":"2559170","version":"1","preferredName":"Medullary Carcinoma","longName":"2559170","preferredDefinition":"Definition not available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medullary Carcinoma","conceptCode":"C8998","definition":"Definition not available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B42F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2010-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8B5C-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Mixed ductal/lobular","valueDescription":"Mixed ductal/lobular","ValueMeaning":{"publicId":"2582310","version":"1","preferredName":"Mixed ductal/lobular","longName":"2582310","preferredDefinition":"Mixed ductal/lobular","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0E93-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-02","modifiedBy":"REEVESD","dateModified":"2006-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8B68-0AD9-E044-0003BA3F9857","beginDate":"2006-12-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Mucinous","valueDescription":"Mucinous adenocarcinoma","ValueMeaning":{"publicId":"2567179","version":"1","preferredName":"Mucinous adenocarcinoma","longName":"2567179","preferredDefinition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucinous Adenocarcinoma","conceptCode":"C26712","definition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D378-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2013-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8B7D-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"None","valueDescription":"None at all","ValueMeaning":{"publicId":"2574138","version":"1","preferredName":"None at all","longName":"2574138","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEA7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CLOHNES","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/22 added alt VM for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8B89-0AD9-E044-0003BA3F9857","beginDate":"2002-09-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Not Present","valueDescription":"Not Present","ValueMeaning":{"publicId":"2581130","version":"1","preferredName":"Not Present","longName":"2581130","preferredDefinition":"Value is not present in a message. This is only defined in messages, never in application data! All values not present in the message must be replaced by the applicable default, or no-information (NI) as the default of all defaults.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"not present","conceptCode":"C1549059","definition":"Value is not present in a message. This is only defined in messages, never in application data! All values not present in the message must be replaced by the applicable default, or no-information (NI) as the default of all defaults.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-09F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2010-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8B9E-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8BAA-0AD9-E044-0003BA3F9857","beginDate":"2002-07-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Paget's Disease","valueDescription":"Paget Disease","ValueMeaning":{"publicId":"2566821","version":"1","preferredName":"Paget Disease","longName":"2566821","preferredDefinition":"A malignant neoplasm composed of large cells with large nuclei, prominent nucleoli, and abundant pale cytoplasm (Paget cells).  Paget's cell neoplasms include Paget's disease of the nipple and extramammary Paget's disease which may affect the vulva, penis, anus, skin and scrotum. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paget Disease","conceptCode":"C7073","definition":"A malignant neoplasm composed of large cells with large nuclei, prominent nucleoli, and abundant pale cytoplasm (Paget cells).  Paget cell neoplasms include Paget disease of the nipple and extramammary Paget disease which may affect the vulva, penis, anus, skin and scrotum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D212-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":"04/13/2011 - tc - Updated with current NCIt name and definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8BB6-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Papillary","valueDescription":"Papillary","ValueMeaning":{"publicId":"2559695","version":"1","preferredName":"Papillary","longName":"2559695","preferredDefinition":"of or relating to or resembling papilla.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary","conceptCode":"C14166","definition":"Of or relating to or resembling papilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B63C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8BC2-0AD9-E044-0003BA3F9857","beginDate":"2002-06-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Poorly Differentiated NOS","valueDescription":"Poorly Differentiated, Not Otherwise Specified","ValueMeaning":{"publicId":"2574527","version":"1","preferredName":"Poorly Differentiated, Not Otherwise Specified","longName":"2574527","preferredDefinition":"Poorly Differentiated, Not Otherwise Specified","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F02C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-18","modifiedBy":"REEVESD","dateModified":"2005-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8BCE-0AD9-E044-0003BA3F9857","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Secretory","valueDescription":"Secretory","ValueMeaning":{"publicId":"2566484","version":"1","preferredName":"Secretory","longName":"2566484","preferredDefinition":"A rare, low grade invasive adenocarcinoma of the breast characterized by the presence of cells that secrete milk-like material. Morphologically, it usually appears as a circumscribed lesion, composed of cystic spaces, tubular structures, and solid areas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Secretory Carcinoma","conceptCode":"C4189","definition":"A rare, low grade invasive adenocarcinoma of the breast characterized by the presence of cells that secrete milk-like material. Morphologically, it usually appears as a circumscribed lesion, composed of cystic spaces, tubular structures, and solid areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0C1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"REEVESD","dateModified":"2013-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8BDA-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Tubular","valueDescription":"Tubular Adenocarcinoma","ValueMeaning":{"publicId":"2560320","version":"1","preferredName":"Tubular Adenocarcinoma","longName":"2560320","preferredDefinition":"An aggressive adenocarcinoma that arises from the sweat glands. It usually presents as a firm, erythematous nodular lesion in the axilla. Morphologically, it is characterized by the presence of tubular structures and apocrine differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sweat Gland Tubular Carcinoma","conceptCode":"C3682","definition":"An aggressive adenocarcinoma that arises from the sweat glands. It usually presents as a firm, erythematous nodular lesion in the axilla. Morphologically, it is characterized by the presence of tubular structures and apocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8AD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8BEF-0AD9-E044-0003BA3F9857","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Fibrocystic change","valueDescription":"Fibrocystic change","ValueMeaning":{"publicId":"2582340","version":"1","preferredName":"Fibrocystic change","longName":"2582340","preferredDefinition":"Fibrocystic change","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0EB1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8BFB-0AD9-E044-0003BA3F9857","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Fat necrosis","valueDescription":"Fat necrosis","ValueMeaning":{"publicId":"2582341","version":"1","preferredName":"Fat necrosis","longName":"2582341","preferredDefinition":"A benign condition in which fat tissue in the breast or other organs is damaged by injury, surgery, or radiation therapy. The fat tissue in the breast may be replaced by a cyst or by scar tissue, which may feel like a round, firm lump. The skin around the lump may look red, bruised or dimpled.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fat Necrosis","conceptCode":"C26772","definition":"Destruction of adipose tissue caused by the activity of lipase on damaged fat cells.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0EB2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8C07-0AD9-E044-0003BA3F9857","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Focal fat necrosis","valueDescription":"Focal fat necrosis","ValueMeaning":{"publicId":"2582342","version":"1","preferredName":"Focal fat necrosis","longName":"2582342","preferredDefinition":"Focal fat necrosis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0EB3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8C13-0AD9-E044-0003BA3F9857","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Biopsy site","valueDescription":"Biopsy site","ValueMeaning":{"publicId":"2582343","version":"1","preferredName":"Biopsy site","longName":"2582343","preferredDefinition":"The anatomic site targeted for a biopsy procedure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biopsy Site","conceptCode":"C77677","definition":"The anatomic site targeted for a biopsy procedure.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0EB4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8C1F-0AD9-E044-0003BA3F9857","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Benign fibroglandular","valueDescription":"Benign fibroglandular","ValueMeaning":{"publicId":"2582344","version":"1","preferredName":"Benign fibroglandular","longName":"2582344","preferredDefinition":"Benign fibroglandular","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0EB5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8C2B-0AD9-E044-0003BA3F9857","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Adenosis","valueDescription":"Adenosis","ValueMeaning":{"publicId":"2580329","version":"1","preferredName":"Adenosis","longName":"2580329","preferredDefinition":"A non-neoplastic disorder characterized by epithelial and/or myoepithelial tissue growth in the breast lobules.  It may be associated with apocrine changes or sclerosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Adenosis","conceptCode":"C3484","definition":"A non-neoplastic disorder characterized by epithelial and/or myoepithelial tissue growth in the breast lobules.  It may be associated with apocrine changes or sclerosis.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-06D6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-07-27","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8C37-0AD9-E044-0003BA3F9857","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Fibroadenoma","valueDescription":"Fibroadenoma","ValueMeaning":{"publicId":"2566468","version":"1","preferredName":"Fibroadenoma","longName":"2566468","preferredDefinition":"This is the most common benign breast lesion.  It usually occurs in premenopausal women.  Diagnostic exams and procedures include: clinical exam, imaging (mammography and ultra sound), and tissue biopsy (fine-needle aspiration or core biopsy). -2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Fibroadenoma","conceptCode":"C3744","definition":"A benign tumor of the breast characterized by the presence of stromal and epithelial elements. It presents as a painless, solitary, slow growing, firm, and mobile mass. It is the most common benign breast lesion. It usually occurs in women of childbearing age. The majority of fibroadenomas do not recur after complete excision. A slightly increased risk of developing cancer within fibroadenomas or in the breast tissue of patients previously treated for fibroadenomas has been reported.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0B1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"REEVESD","dateModified":"2010-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8C43-0AD9-E044-0003BA3F9857","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Fibrosis","valueDescription":"Fibrosis","ValueMeaning":{"publicId":"2563316","version":"1","preferredName":"Fibrosis","longName":"2563316v1.00","preferredDefinition":"The formation of fibrous tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrosis","conceptCode":"C3044","definition":"The formation of fibrous tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C461-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8C4F-0AD9-E044-0003BA3F9857","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Normal Breast","valueDescription":"Normal Breast","ValueMeaning":{"publicId":"2582345","version":"1","preferredName":"Normal Breast","longName":"2582345","preferredDefinition":"Normal Breast","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0EB6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8C5B-0AD9-E044-0003BA3F9857","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Fibroglandular","valueDescription":"Fibroglandular","ValueMeaning":{"publicId":"2582346","version":"1","preferredName":"Fibroglandular","longName":"2582346v1.00","preferredDefinition":"Breast tissue that contains glandular epithelial and fibrous tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Fibroglandular Tissue","conceptCode":"C114467","definition":"Breast tissue that contains glandular epithelial and fibrous tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0EB7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8C67-0AD9-E044-0003BA3F9857","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Fibroadipose","valueDescription":"Fibroadipose","ValueMeaning":{"publicId":"2582348","version":"1","preferredName":"Fibroadipose","longName":"2582348","preferredDefinition":"Fibroadipose","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0EB9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8C7F-0AD9-E044-0003BA3F9857","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Muscle","valueDescription":"Muscle","ValueMeaning":{"publicId":"2578073","version":"1","preferredName":"Muscle","longName":"2578073","preferredDefinition":"Muscle; one of the contractile organs of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Muscle","conceptCode":"C13056","definition":"One of the contractile organs of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FE06-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-04","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-04","modifiedBy":"REEVESD","dateModified":"2010-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23DA9DCA-8C8B-0AD9-E044-0003BA3F9857","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"REEVESD","dateModified":"2006-12-05","deletedIndicator":"No"},{"value":"Mixed Histology","valueDescription":"Mixed Histology","ValueMeaning":{"publicId":"3084098","version":"1","preferredName":"Mixed Histology","longName":"3084098","preferredDefinition":"An invasive breast carcinoma containing both ductal and lobular carcinomatous components.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Mixed Carcinoma","conceptCode":"C40347","definition":"An invasive breast carcinoma characterized by the presence of more than one malignant epithelial histologic pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8638268D-A4B9-7AFE-E040-BB89AD43791D","latestVersionIndicator":"Yes","beginDate":"2010-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8DA5AC48-796D-E2FD-E040-BB89AD4306E2","beginDate":"2010-08-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-12","modifiedBy":"ONEDATA","dateModified":"2010-08-12","deletedIndicator":"No"},{"value":"Infiltrating Carcinoma, NOS","valueDescription":"Invasive Breast Carcinoma","ValueMeaning":{"publicId":"3128153","version":"1","preferredName":"Invasive Breast Carcinoma","longName":"3128153","preferredDefinition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women. --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma","conceptCode":"C9245","definition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DA5AC48-7978-E2FD-E040-BB89AD4306E2","latestVersionIndicator":"Yes","beginDate":"2010-08-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8DA5AC48-7991-E2FD-E040-BB89AD4306E2","beginDate":"2010-08-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-12","modifiedBy":"ONEDATA","dateModified":"2010-08-12","deletedIndicator":"No"},{"value":"Adipose","valueDescription":"Adipose Tissue","ValueMeaning":{"publicId":"2574799","version":"1","preferredName":"Adipose Tissue","longName":"2574799","preferredDefinition":"Connective tissue composed of fat cells lodged in the meshes of areolar tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adipose Tissue","conceptCode":"C12472","definition":"A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F13C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-17","modifiedBy":"FINCHAMB","dateModified":"2023-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8DA5AC48-799B-E2FD-E040-BB89AD4306E2","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-12","modifiedBy":"ONEDATA","dateModified":"2010-08-12","deletedIndicator":"No"},{"value":"Apocrine","valueDescription":"Apocrine Neoplasm","ValueMeaning":{"publicId":"3128155","version":"1","preferredName":"Apocrine Neoplasm","longName":"3128155v1.00","preferredDefinition":"A benign or malignant sweat gland neoplasm with apocrine differentiation. Representative examples include apocrine adenoma, ceruminous adenocarcinoma, and apocrine breast carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Apocrine Neoplasm","conceptCode":"C6798","definition":"A benign or malignant sweat gland neoplasm with apocrine differentiation. Representative examples include apocrine adenoma, ceruminous adenocarcinoma, and apocrine breast carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DA5AC48-79A9-E2FD-E040-BB89AD4306E2","latestVersionIndicator":"Yes","beginDate":"2010-08-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-12","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8DA5AC48-79C2-E2FD-E040-BB89AD4306E2","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-12","modifiedBy":"ONEDATA","dateModified":"2010-08-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2549635","version":"1","preferredName":"Breast Carcinoma Histologic Type","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002:Of or relating to histology.:Type; a subdivision of a particular kind of thing.","longName":"C4872:C25526:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23DA9DBB-D7C8-0A8B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"ONEDATA","dateModified":"2006-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23DA9DBB-D7D9-0A8B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"HARTLEYG","dateModified":"2016-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812583","version":"1","longName":"Panvec","context":"NCIP"},{"publicId":"2812724","version":"1","longName":"Duke U New CDEs","context":"NCIP"},{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]}],"AlternateNames":[{"name":"DCI","type":"USED_BY","context":"DCI"}],"ReferenceDocuments":[{"name":"Histologic tissue type","type":"Preferred Question Text","description":"Histologic tissue type","url":null,"context":"NCIP"},{"name":"Histological Type","type":"Alternate Question Text","description":"Histological Type","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"23DACBD8-7B45-1080-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-05","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"Curated to support Duke University adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}